• About Amgen
  • Science
  • Corporate Philanthropy
  • Sitemap
  • Search
  • Privacy & Terms
  • Contact Us
Amgen
  • Health Information
  • Careers
  • Media
  • print
  • mail
  • Home
  • Media
  • Press Releases

  • Overview
  • Press Releases
  • In The News
  • Fact Sheets
  • Media Contacts

Date Title
5/6/2010 Amgen Canada Holds Hands With Local Community
  Amgen Canada, today announced the local programs selected to receive support through its new community philanthropy initiative, Holding Hands, at an employee launch celebration
more >
11/19/2009 Call For Applications: The Amgen Award for Science Teaching Excellence (AASTE)
  Amgen today announced that applications for the 19th Annual Amgen Award for Science and Teaching Excellence (AASTE) are now being accepted.
more >
8/11/2009 Studies published in the New England Journal of Medicine highlight potential new option in the treatment of bone loss
  Amgen today announced the publication of results from two pivotal Phase 3 studies investigating the safety and effectiveness of denosumab at reducing fracture risk in more than 7,800 women with postmenopausal osteoporosis more >
6/23/2009 Health Canada issues Notice of Compliance (NOC) for the first and only platelet producer indicated for the treatment of immune (idiopathic) thrombocytopenic purpura (ITP)
  Amgen Canada announced today that Health Canada has issued a Notice of Compliance (NOC) for NplateTM (romiplostim)
more >
6/17/2009 2009 Recipients Recognized in Communities Across Canada
  Today, Amgen announced the four Canadian science teachers who are this year’s recipients of the Amgen Award for Science Teaching Excellence (AASTE)
more >
12/3/2008 Ontario takes a bold step towards personalized medicine
  First province to reimburse new, innovative therapy for Colorectal Cancer
more >
11/1/2008 Amgen offers $10,000 teaching award
  Amgen expands award for science teaching excellence to (AASTE) to recognize outstanding teachers in four provinces more >
6/10/2008 Amgen celebrates new corporate office
  Amgen Canada celebrated its grand opening today and announced the first Ontario recipient of the Amgen Award for Science Teaching Excellence (AASTE) at a special ceremony presided by local dignitaries and leaders in the Mississauga business community more >
5/15/2008 Health Canada approves 'personalized medicine' for metastatic colorectal cancer
  The first and only treatment of its kind in Canada for metatstatic colorectal cancer has received conditional* approval from Health Canada. VectibixTM (panitumumab) represents an important new option for colorectal cancer patients whose disease has           more >
5/13/2008 Amgen Canada honours outstanding educator in British Columbia
 
Amgen Canada is delighted to recognize Gregg Mitchell, of Timberline Secondary School, as the winner of the 2008 Amgen Award for Science Teaching Excellence (AASTE) as result of his outstanding ability to inspire students and produce results in science education.
more >
footer